Holen Sie sich die Stockscreener-App
0.4851
5.70%
-0.0293
Handel nachbörslich:
.49
0.0049
+1.01%
Schlusskurs vom Vortag:
$0.5144
Offen:
$0.5144
24-Stunden-Volumen:
626.44K
Relative Volume:
2.77
Marktkapitalisierung:
$747.73K
Einnahmen:
$743.00K
Nettoeinkommen (Verlust:
$-7.63M
KGV:
-0.1617
EPS:
-3
Netto-Cashflow:
-
1W Leistung:
-19.43%
1M Leistung:
-26.46%
6M Leistung:
-62.68%
1J Leistung:
-80.75%
1-Tages-Spanne:
$0.473
$0.5144
1-Wochen-Bereich:
$0.473
$0.6022
52-Wochen-Spanne:
$0.473
$3.12
Can-Fite Biopharma Ltd ADR Stock (CANF) Company Profile
Firmenname
Can-Fite Biopharma Ltd ADR
Sektor
Branche
Telefon
972 3 924 1114
Adresse
10 Bareket Street, Kiryat Matalon PO Box 7537, Petah-Tikva
Vergleichen Sie CANF mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CANF
Can-Fite Biopharma Ltd ADR
|
0.4851 | 8.78M | 743.00K | -7.63M | 0 | -3.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Can-Fite Biopharma Ltd ADR Stock (CANF) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2017-08-11 | Eingeleitet | Maxim Group | Buy |
| 2016-10-19 | Fortgesetzt | ROTH Capital | Buy |
| 2016-08-29 | Fortgesetzt | Rodman & Renshaw | Buy |
| 2015-11-30 | Bestätigt | H.C. Wainwright | Buy |
| 2015-03-31 | Bestätigt | H.C. Wainwright | Buy |
| 2015-03-30 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2014-12-29 | Bestätigt | ROTH Capital | Buy |
| 2014-11-18 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Can-Fite Biopharma Ltd ADR Aktie (CANF) Neueste Nachrichten
Will Can Fite Biopharma Ltd Sponsored ADR stock beat growth indexesJuly 2025 Big Picture & AI Enhanced Trading Alerts - newser.com
Why Can Fite Biopharma Ltd Sponsored ADR stock could outperform next yearGlobal Markets & Weekly Return Optimization Alerts - newser.com
Why pension funds invest in Can Fite Biopharma Ltd Sponsored ADR stockJuly 2025 Selloffs & Reliable Trade Execution Plans - newser.com
Why Can Fite Biopharma Ltd Sponsored ADR stock fits value portfolios2025 Bull vs Bear & Smart Allocation Stock Reports - newser.com
Is Can Fite Biopharma Ltd Sponsored ADR stock expanding market penetration2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com
Is Can Fite Biopharma Ltd Sponsored ADR stock a contrarian opportunityEarnings Miss & Real-Time Volume Triggers - newser.com
Why Can Fite Biopharma Ltd Sponsored ADR stock is a strong buy callEarnings Beat & High Accuracy Swing Entry Alerts - newser.com
Analyzing recovery setups for Can Fite BioPharma Ltd. Depositary Receipt investorsJuly 2025 Sector Moves & AI Driven Stock Movement Reports - newser.com
Institutional scanner results for Can Fite BioPharma Ltd. Depositary ReceiptMarket Performance Recap & Smart Money Movement Alerts - newser.com
Developing predictive dashboards with CISS dataTreasury Yields & Technical Analysis for Trade Confirmation - newser.com
Is a relief rally coming for Inovio Pharmaceuticals Inc. holders2025 Technical Overview & Risk Controlled Swing Trade Alerts - newser.com
Smart tools for monitoring Can Fite BioPharma Ltd. Depositary Receipt’s price action2025 Market Overview & Precise Buy Zone Tips - newser.com
Order flow analysis tools used on BOOMWatch List & Accurate Technical Buy Alerts - newser.com
Can-Fite BioPharma (NYSE:CANF) Given Buy Rating at D. Boral Capital - Defense World
Can swing trading help recover from Crane NXT Co. lossesMarket Growth Summary & AI Optimized Trade Strategies - Newser
Has FVRR formed a bullish divergence2025 Key Lessons & Low Risk High Win Rate Picks - Newser
Applying sector rotation models to Vale S.A. Depositary ReceiptJuly 2025 Catalysts & Reliable Price Action Trade Plans - Newser
Sentiment analysis tools applied to Vertical Aerospace Ltd.2025 Dividend Review & Weekly Setup with ROI Potential - Newser
Using RSI to spot recovery in ALDFUJuly 2025 Market Mood & Precise Swing Trade Entry Alerts - Newser
Finanzdaten der Can-Fite Biopharma Ltd ADR-Aktie (CANF)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):